Arsenic Trioxide in Treating Patients With Pancreatic Cancer That Has Not Responded to Gemcitabine
Clinical trial NCT00053222 · COMPLETED
Trial details
- NCT number
- NCT00053222
- Sponsor
- University of Chicago
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-02-01
- Primary completion
- 2005-01-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.